Navigation Links
Poniard Pharmaceuticals Announces Upcoming Conference Participation
Date:2/4/2008

SOUTH SAN FRANCISCO, Calif., Feb. 4 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD), a biopharmaceutical company focused on oncology, today announced that Jerry McMahon, Ph.D., chairman and CEO, will present at the 10th Annual BIO CEO & Investor Conference 2008 on Monday, February 11, at 11:45 a.m. Eastern Time at the Waldorf-Astoria in New York.

Dr. McMahon will provide a corporate overview, including a discussion of the clinical development program for picoplatin, the Company's lead product candidate.

A live audio webcast of the presentation will be available for 10 business days on the "Events" page of the "News & Events" section of the Company's website at http://www.poniard.com.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. Picoplatin, the Company's lead platform product candidate, is a new generation platinum therapy with an improved safety profile compared to currently available platinum-based therapies. Picoplatin is designed to overcome and prevent platinum resistance associated with chemotherapy in solid tumors, and is being studied in multiple cancer indications, combinations and formulations. Clinical trials of intravenous picoplatin include a Phase 3 trial in small cell lung cancer and Phase 2 trials in metastatic colorectal and hormone-refractory prostate cancers. For additional information please visit http://www.poniard.com.

(C) 2008 Poniard Pharmaceuticals, Inc. All Rights Reserved. Poniard and Poni
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...Force A-Line Athletic Mat is great. It,s a very g...or and physician best known for establishing and p... to www.yogaforce.com and order the new Mat toda... San Francisco, CA (PRWEB) Nove...e YogaForce newly patented, revolutionary A-Line A...
(Date:11/28/2009)...re/ -- Welcome to syngo® .plaza(1), t...e from Siemens Healthcare. As the first Pict...rom Siemens where 2D, 3D, and 4D reading come toge...change the way multimodality images are read today...th Scientific Assembly and Annual Meeting of the R...
(Date:11/28/2009)...sider change after 30-minute psychosocial interven...ealthDay News) -- A program that gets persistent d...r dangerous behavior may lead to significant and l...The new study included 184 men and women with two ...re randomly assigned to one of two interventions. ...
(Date:11/28/2009)... recognize signs of depression , , SATUR... the holiday season can trigger melancholy as they... issues or worry about money problems, according t...ercome the seasonal blues, the AGS Foundation for ...et out and socialize or invite family and friends ...
(Date:11/27/2009)...ire/ - Uploadable USB pedometers may be new, but t...mbination of advanced accelerometer functionality ...concern over the accuracy of self-reported data. I...proved participation in a fitness program. ,, C...s suppliers to integrate this technology. "Our hea...
Breaking Medicine News(10 mins):Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:New USB technology adds accountability and convenience to wellness programs 2
...icial and healthy activity. With the emphasis slow...xperts opine// that there’s nothing like a bit of ... Roth of the Wellness Institute at Northwestern Me... you a good way to burn calories that's an enjoyab...
...id of the computers are sought in order to develop...ndy //as they have the ability to perform difficul...ut any rest. They are good at handling long and co... from particle physics experiments were used by sc...
...syndrome is a common type of disorder in which the...n their legs//. For the first time Europe has appr... affects the nerves and causes aches and pains. St...used to treat mild to moderate or severe cases of ...
...of disorder in which in which the bone marrow stop...his the patients lack enough// number of RBCs and ...ical symptoms include weakness, fatigue, infection...ns promote the normal development of blood cells. ...
...evice that targets sperms, called Intra Vas Device...involving 90 men. Men and women have long been pro...ill. However, this first male contraceptive to be ...ser to having their first new contraceptive in mor...
...accine believed to protect against chancroid, a se..., it could put an end to this devastating disease ...uld eventually result in a 10-fold reduction in tr...the World Health Organization, and efforts to deve...
Other Medicine News:Health News:Burn Away Calories In Your Garden 2Health News:Non-Hormonal Male Contraceptive Based on Sperm Block Underway 2Health News:Chancroid Vaccine Holds Promise In Reducing HIV Transmission 2Health News:Chancroid Vaccine Holds Promise In Reducing HIV Transmission 3
(Date:11/29/2009)..., Nov. 29 FUJIFILM Medical Systems...s revolutionary flat panel DR cassette, at the 200...ual Meeting. Ideal for any clinical environment, ...vide clinicians with Fujifilm,s trademark image qu...s a smart way for users to transition to DR withou...
(Date:11/29/2009)..., Nov. 29 Researchers using functi...ain activation have found that men and women respo...ccording to a study presented today at the annual ...ca (RSNA). ,, "Men may direct more attention to...process them in terms of implications for required...
(Date:11/27/2009)...TON, Minn, Nov. 27 ACUO TECHNOLOGI...anagement software, data migration tools and servi... Patent and Trademark Office has approved a patent...thin a Computer Network." Acuo Technologies is ple...tellectual property. In general, the granted paten...
Breaking Medicine Technology:FUJIFILM's DR Cassette Makes World Debut 2New Study Finds Men and Women May Respond Differently to Danger 2New Study Finds Men and Women May Respond Differently to Danger 3Acuo Technologies Announces Patent for Asset Communication Format Within a Computer Network 2Anxious Kids at Risk for Obesity in Adulthood 57251 1Anxious Kids at Risk for Obesity in Adulthood 57251 2Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 1Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 2Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 3Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 1Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 2
...ollowing Success with 8 Patients, PRINCETON, N.J....), a provider of advanced wound care products, tod...oracic surgeons from the,University of Wurzburg, G...ssfully treat 8 patients with deep sternal wound i...s after open-heart surgeries. The dressings,were u...
...LC, the clinical trial,management provider for Foc... announce conditional written approval pending min... pivotal trial for the treatment of,recurrent pros...ave failed,external beam radiation therapy., Dr. ...f Medicine and,medical monitor for the trial said,...
Other Medicine Technology:Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures 2Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures 3FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer 2
...a rigid shell with a vacuum liner used to provide ...int is a non-weight bearing splint. Once the patie...r to the STORM walker boot., ,Patients requiring ...om the STORM and insert the vacuum liner from the ...
Bledsoe M-Brace Ankle Support
...Boot is designed as a flexible and attractive alte...mid-foot area and also for second and third degree...Bledsoe Hi-Top Boot but offers similar support. Th... of motion from 20 degrees of dorsi-flexion to 40 ...
Bledsoe Breeze Boot
Medicine Products: